We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Share Name | Share Symbol | Market | Type | Share ISIN | Share Description |
---|---|---|---|---|---|
Wameja Limited | LSE:WJA | London | Ordinary Share | AU0000053472 | ORD NPV (DI) |
Price Change | % Change | Share Price | Bid Price | Offer Price | High Price | Low Price | Open Price | Shares Traded | Last Trade | |
---|---|---|---|---|---|---|---|---|---|---|
0.00 | 0.00% | 7.90 | 7.80 | 8.00 | - | 0.00 | 01:00:00 |
Industry Sector | Turnover | Profit | EPS - Basic | PE Ratio | Market Cap |
---|---|---|---|---|---|
0 | 0 | N/A | 0 |
Date | Subject | Author | Discuss |
---|---|---|---|
09/9/2020 09:57 | If you take into consideration the capital raised and share dilution 10p is not a good return for share holders. I think 20p has already been agreed with MC. | hibberts | |
09/9/2020 09:11 | Tomb,Directors hold a very small % of WJA. They won't have much of a say. If MC came along and offered 10p equivalent (when converted into wja share price) for the WJA shares in homesend, most institutions and PI may (having made a profit) say yes. The directors can make recommendations to shareholders, but could not refuse to tell shareholders an offer had been made. | fft | |
09/9/2020 07:16 | The directors have options to buy shares at 17p, even after a bid. So it will be already 20p bid, if MC wants Wameja | tomv33 | |
08/9/2020 22:53 | Tomv33 / 20P? The house broker suggested that Wameja’s share of HomeSend revenue for 2019 was circa €3.6m. If(?) Q4 2019 Wameja’s share of HomeSend’s revenue was €1m… and if… the increase in gross value flows Q-to-Q is equivalent to the revenue attributable to HomeSend… Q1 2020 – 33.8% increase over prior quarter gross value flows – say €1.338M? Q2 2020 – 93.2% increase over prior quarter gross value flows – say €2.582M? More organisations have signed up to Mastercard Send (HomeSend) in 2020, and some others since H1 2020. Say Q-to-Q were to “increase over prior quarter gross value flows” by 25%(??) till the end of 2021… Q3 2020 – 25% increase over prior quarter gross value flows – say €3.227M? Q4 2020 – 25% increase over prior quarter gross value flows – say €4.034M? 2020 = €11.181M? Q1 2021 – 25% increase over prior quarter gross value flows – say €5.042M? Q2 2021 – 25% increase over prior quarter gross value flows – say €6.303M? Q3 2021 – 25% increase over prior quarter gross value flows – say €7.878M? Q4 2021 – 25% increase over prior quarter gross value flows – say €9.848M? Wameja revenue 2021 = €29.071m? Mastercard trade on a multiple of circa 27/28X earnings whilst Mastercard and Visa’s most recent / notable acquisitions were circa 50X earnings. Q3 results will be interesting... | mcmather | |
08/9/2020 12:19 | FWIW the 500k 'sell' reported at 9:03 is a late reported trade from yesterday so almost certainly a buy. | the skipper | |
07/9/2020 22:07 | The minimum this will go for is 20p, Okay? | tomv33 | |
07/9/2020 13:58 | MC do give a toss, the directors have got to agree to the price. If it's too low they will stick their middle fingers up and not take it! | tomv33 | |
07/9/2020 09:27 | Suspect there may be some bid action here soon | lucicavi | |
07/9/2020 08:49 | Dr Bio, what the article does do is give a figure from the house broker; "Wameja’s share of the HS earnings in that year would be €3.6m" for last year. Since when, there's been the 2 quarterly updates and details of those who have signed up with Mastercard Send (H/S). | mcmather | |
07/9/2020 08:04 | Dr Biotech - good, realistic and concise summary ! | masurenguy | |
07/9/2020 07:24 | Of course I know what they do, I’ve tracked these since they were eserveglobal. No ones going to bid a large amount for a company they can’t control, and if MC do bid they won’t give a toss about Director options. To me it’s a decent growth story, which is why I bought in. | dr biotech | |
06/9/2020 23:53 | Someone who can clearly see the profit from Homesend in the future will counter bid. A junior partner... they own more than 30% so MC cannot do anything without their permission and vice versa! This will expand rapidly so any company with a 'minor' decent cash value would be able to counter bid.... are you okay? | tomv33 | |
06/9/2020 23:51 | You do not see a huge premium here? Do you even know what homesend is and the factors with this bid?! Wameja owns 35%, MC own the rest, mastercard want the other 35% as this will be making profit soon. The director has bought over 2.5 million shares with his wife! And an option to buy more at 17p. He wont sell this for less than 17p at the minimum... | tomv33 | |
06/9/2020 18:47 | I have a few here after the scsw article. Less than 1% of my total holdings. I’ve decided to follow some of their tips, their record is much better than mine..have done ok so far with 6 winners and 2 losers I am sceptical of some of the things written - Finncap always seem to have a price target way above the current share price for all their write ups. The anonymous article on the largely anonymous website above I give almost zero credibility. I don’t see why MC will pay a huge premium, but it’s does look like a decent growth story and hopefully profitability over the near future. | dr biotech | |
06/9/2020 16:06 | No one is going to counter bid to be a junior partner with Mastercard. The only alternate take out is someone offering to buy Homesend from both parties. Which is unlikely if it's a viable business. It's Schrodingers takeover. WJA is the box, Homesend is the cat. We and everyone else are on the outside looking at the box, wondering how it's going. Mastercard are inside the box with the cat. | kinbasket | |
06/9/2020 14:23 | Yes I see the finncap has bought up the possibility of a second bidder or a counter bid | tomv33 | |
06/9/2020 13:21 | Worth re-visiting this piece from 28 Feb 2020: Lorne Daniel, Director of Research at house broker FinnCap, has previously written how it is has effectively been de-risked as an investment. In his latest note, published today, he writes: "....Cross border remains a key area of growth for the US financials giant. Mastercard shares currently trade on a multiple of 28x 2022E earnings. Wameja’s share of the HS earnings in that year would be €3.6m, valuing that stake on simply financial benefit at over €100m or £85m. Beyond that, there is the value of full control over a key element of its digital money strategy as well as greater confidentiality (since Wameja’s public listing somewhat exposes HS performance). We remain confident that Mastercard will bid a substantial sum for that stake, whether or not it is the final buyer.” | mcmather | |
04/9/2020 12:35 | It has been a year now that JC did his interview with Tazmin on piworld. If he doesn't do another then you know the end is nigh. | johnv | |
04/9/2020 12:26 | Someone is simply trading this, buys under 5, sells around 6p, been going on for ages and I expect will keep going on unless MC takes wja out. The directors do very little to promote wja who are probs stifled by MC from saying much at all. | celeritas | |
04/9/2020 12:22 | I can only assume that it is it's clients who are spread getting on WJA one way or the other. | johnv | |
04/9/2020 09:42 | what is spreadex doing rns- good or bad? | ali47fish | |
04/9/2020 08:36 | That reads well...... Hopefully before 2020 is out..... | soundbuy |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions